Silverberg J, Anderson P, Cappelleri J, Piercy J, Levenberg M, Myers D
Arch Dermatol Res. 2025; 317(1):556.
PMID: 40072609
PMC: 11903610.
DOI: 10.1007/s00403-025-03910-y.
Calzavara-Pinton P, Chu C, Lapeere H, Rossi M, Ferrucci S, Chung W
Adv Ther. 2024; 42(2):720-733.
PMID: 39621227
PMC: 11787152.
DOI: 10.1007/s12325-024-03049-8.
Lugovic-Mihic L, Barac E, Tomasevic R, Parac E, Zanze L, Ljevar A
Pharmaceuticals (Basel). 2024; 17(11).
PMID: 39598368
PMC: 11597550.
DOI: 10.3390/ph17111455.
Stratigos A, Chasapi V, Katoulis A, Vakirlis E, Psarros F, Georgiou S
J Clin Med. 2024; 13(21).
PMID: 39518471
PMC: 11546607.
DOI: 10.3390/jcm13216327.
Alradaddi A, Al Twaim A, Abu-Aliat A, Al-Atass K, Alogayell L, Aldayil M
Dermatol Res Pract. 2024; 2022:5636903.
PMID: 39444785
PMC: 11496595.
DOI: 10.1155/2022/5636903.
Investigation of the Impact of Atopic Dermatitis (AD) on Stress, Depression, Anxiety, and Suicidal Ideation: A Systematic Review and Meta-Analysis.
Almutawa Y, AlGhareeb M, Bhattarai E, Aljalahma J
Cureus. 2024; 16(6):e63376.
PMID: 39077283
PMC: 11283933.
DOI: 10.7759/cureus.63376.
Capturing patient-reported sleep disturbance in atopic dermatitis clinical trials.
Dias-Barbosa C, Silverberg J, Stander S, Rodriguez D, Fofana F, Filipenko D
J Patient Rep Outcomes. 2024; 8(1):73.
PMID: 39008191
PMC: 11250737.
DOI: 10.1186/s41687-024-00751-7.
The Impact of Atopic Dermatitis on Sexual Function and Reproductive Desires in Women.
Rodriguez-Pozo J, Montero-Vilchez T, Diaz Calvillo P, Sanabria de la Torre R, Urena Paniego C, Ramirez-Munoz A
Acta Derm Venereol. 2024; 104:adv35107.
PMID: 38860625
PMC: 11181923.
DOI: 10.2340/actadv.v104.35107.
Impact of Atopic Dermatitis on Adult Women's Lives: A Survey of 1,009 French Women.
Fougerousse A, Alexandre M, Darrigade A, Merhand S, Marquie A, Hamza M
Acta Derm Venereol. 2024; 104:adv10321.
PMID: 38738770
PMC: 11107838.
DOI: 10.2340/actadv.v104.10321.
An Overview on Atopic Dermatitis, Oxidative Stress, and Psychological Stress: Possible Role of Nutraceuticals as an Additional Therapeutic Strategy.
Alessandrello C, Sanfilippo S, Minciullo P, Gangemi S
Int J Mol Sci. 2024; 25(9).
PMID: 38732239
PMC: 11084351.
DOI: 10.3390/ijms25095020.
Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis.
Torres T, Sohrt Petersen A, Ivens U, Bosch Vilaro A, Stinson J, Carrascosa J
Dermatol Ther (Heidelb). 2024; 14(4):983-992.
PMID: 38613642
PMC: 11052979.
DOI: 10.1007/s13555-024-01143-x.
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2).
Silverberg J, Gooderham M, Paller A, Deleuran M, Bunick C, Stein Gold L
Am J Clin Dermatol. 2024; 25(3):485-496.
PMID: 38528257
PMC: 11070400.
DOI: 10.1007/s40257-024-00853-4.
Ethnic differences in depression and anxiety among adults with atopic eczema: Population-based matched cohort studies within UK primary care.
Adesanya E, Henderson A, Hayes J, Lewin A, Mathur R, Mulick A
Clin Transl Allergy. 2024; 14(3):e12348.
PMID: 38526449
PMC: 10962487.
DOI: 10.1002/clt2.12348.
Burden of Disease in the Real-Life Setting of Patients with Atopic Dermatitis: Italian Data From the MEASURE-AD Study.
Argenziano G, Mercuri S, Savoia P, Amerio P, Belloni Fortina A, Bongiorno M
Dermatol Pract Concept. 2023; 14(1).
PMID: 38048260
PMC: 10868859.
DOI: 10.5826/dpc.1401a79.
Abnormal brain structure in atopic dermatitis: Evidence from Mendelian randomization study.
Chen Y, Cui L, Li H, Gao A
Skin Res Technol. 2023; 29(11):e13515.
PMID: 38009032
PMC: 10654478.
DOI: 10.1111/srt.13515.
Baseline Demographics, Comorbidities, Treatment Patterns and Burden of Atopic Dermatitis in Adults and Adolescents from the GLOBOSTAD Long-Term Observational Study.
Calzavara-Pinton P, celakovska J, Lapeere H, Holzer G, Al-Ahmad M, Chu C
Adv Ther. 2023; 40(12):5366-5382.
PMID: 37801232
PMC: 10611842.
DOI: 10.1007/s12325-023-02644-5.
The long-term safety of topical corticosteroids in atopic dermatitis: A systematic review.
Harvey J, Lax S, Lowe A, Santer M, Lawton S, Langan S
Skin Health Dis. 2023; 3(5):e268.
PMID: 37799373
PMC: 10549798.
DOI: 10.1002/ski2.268.
Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-2.
Yosipovitch G, Gooderham M, Stander S, Fonacier L, Szepietowski J, Deleuran M
Am J Clin Dermatol. 2023; 25(1):127-138.
PMID: 37624488
PMC: 10796557.
DOI: 10.1007/s40257-023-00810-7.
Societal costs and health related quality of life in adult atopic dermatitis.
Beretzky Z, Koszoru K, Rencz F, Hajdu K, Borza J, Bodai K
BMC Health Serv Res. 2023; 23(1):859.
PMID: 37580792
PMC: 10426091.
DOI: 10.1186/s12913-023-09840-7.
Long-Term Effectiveness of Dupilumab in Patients with Atopic Dermatitis: Results up to 3 Years from the RELIEVE-AD Study.
Kimball A, Delevry D, Yang M, Chuang C, Wang Z, Bego-Le-Bagousse G
Dermatol Ther (Heidelb). 2023; 13(9):2107-2120.
PMID: 37552431
PMC: 10442302.
DOI: 10.1007/s13555-023-00965-5.